Meeting
2018 ASCO Annual Meeting
Evaluating intermittent dosing of aspirin for colorectal cancer prevention.
Authors
Katrina M. Alber
Northwestern University, Chicago, IL
Katrina M. Alber , Harvey Murff , Reid Ness , Douglas Seidner , Xiangzhu Zhu , Martha Shrubsole , Mary Beth Tull , Kelly A. Benante , Adrian J. Segura , Kiril Kalinichenko , Lifang Hou , Borko Jovanovic , Gary Della'Zanna , Ellen Richmond , Seema Ahsan Khan , Qi Dai
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention, Hereditary Genetics, and Epidemiology
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Prevention
Clinical Trial Registration Number
NCT02965703
Citation
J Clin Oncol 36, 2018 (suppl; abstr TPS1594)
DOI
10.1200/JCO.2018.36.15_suppl.TPS1594
Abstract #
TPS1594
Poster Bd #
165a
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Aspirin as adjuvant treatment for colorectal cancer: Rationale and progress of the Add-Aspirin trial.
First Author: Ruth E Langley
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Bleeding and thrombotic events in patients with colorectal cancer treated with bevacizumab and receiving novel oral anticoagulants and antiplatelet medications.
First Author: Shinji Rho
Poster
2020 ASCO Virtual Scientific Program
Green tea extract to prevent colorectal adenomas in men and women: Results of the MIRACLE trial.
First Author: Thomas Jens Ettrich
Poster
2019 ASCO Annual Meeting
Efficacy of aspirin for stage III colorectal cancer: A randomized double-blind placebo-controlled trial (JCOG1503C, EPISODE-III trial).
First Author: Atsuo Takashima